Notch: A new player in MS mechanisms

Journal of Neuroimmunology

Volumn 218, Issue 1-2, 2010, Pages 3-11

  Juryńczyk, Maciej ^a   Selmaj, Krzysztof ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Autoimmunity; Gamma secretase inhibitors; Multiple sclerosis; Notch; Remyelination

Indexed keywords

ANTIBODY; DELTA1 ANTIBODY; GAMMA SECRETASE INHIBITOR; JAGGED1 FC; MW 167; N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE; NOTCH RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL POLARITY; DEMYELINATION; DENDRITIC CELL; DRUG EFFECT; DRUG TARGETING; ENCEPHALOMYELITIS; GLIA CELL; HELPER CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LYMPHOCYTE DIFFERENTIATION; MACROPHAGE; MICROGLIA; MULTIPLE SCLEROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REGULATORY T LYMPHOCYTE; REMYELINIZATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANIMALS; HUMANS; MULTIPLE SCLEROSIS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 73349100648     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.08.010     Document Type: Review

References (63)

1. Adler S.H., Chiffoleau E., Xu L., Dalton N.M., Burg J.M., Wells A.D., Wolfe M.S., Turka L.A., and Pear W.S. Notch signaling augments T cell responsiveness by enhancing CD25 expression vol. 171 (2003) 2896-2903
2. Amsen D., Blander J.M., Lee G.R., Tanigaki K., Honjo T., and Flavell R.A. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell 117 (2004) 515-526
3. Amsen D., Antov A., Jankovic D., Sher A., Radtke F., Souabni A., Busslinger M., McCright B., Gridley T., and Flavell R.A. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity 27 (2007) 89-99
4. Anastasi E., Campese A.F., Bellavia D., Bulotta A., Balestri A., Pascucci M., Checquolo S., Gradini R., Lendahl U., Frati L., Gulino A., Di Mario U., and Screpanti I. Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes. J. Immunol. 171 (2003) 4504-4511
5. Anderson A.C., Kitchens E.A., Chan S.W., St Hill C., Jan Y.N., Zhong W., and Robey E.A. The Notch regulator Numb links the Notch and TCR signaling pathways. J. Immunol. 174 (2005) 890-897
6. Artavanis-Tsakonas S., Rand M.D., and Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 284 (1999) 770-776
7. Bateman R.J., Siemers E.R., Mawuenyega K.G., Wen G., Browning K.R., Sigurdson W.C., Yarasheski K.E., Friedrich S.W., Demattos R.B., May P.C., Paul S.M., and Holtzman D.M. A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system. Ann. Neurol. 66 (2009) 48-54
8. Beatus P., Lundkvist J., Oberg C., and Lendahl U. The notch3 intracellular domain represses notch 1-mediated activation through Hairy/Enhancer of split (HES) promoters. Development 126 (1999) 3925-3935
9. Benson R.A., Adamson K., Corsin-Jimenez M., Marley J.V., Wahl K.A., Lamb J.R., and Howie S.E. Notch1 co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production. Eur. J. Immunol. 35 (2005) 859-869
10. Bugeon L., Gardner L.M., Rose A., Gentle M., and Dallman M.J. Cutting edge: Notch signaling induces a distinct cytokine profile in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production. J. Immunol. 181 (2008) 8189-8193
11. Cao Q., Lu J., Kaur C., Sivakumar V., Li F., Cheah P.S., Dheen S.T., and Ling E.A. Expression of Notch-1 receptor and its ligands Jagged-1 and Delta-1 in amoeboid microglia in postnatal rat brain and murine BV-2 cells. Glia 56 (2008) 1224-1237
12. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., McGrady G., and Wahl S.M. Conversion of peripheral CD4 + CD25-naïve T cells to CD4 + CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198 (2003) 1875-1886
13. Cheng P., Zlobin A., Volgina V., Gottipati S., Osborne B., Simel E.J., Miele L., and Gabrilovich D.I. Notch-1 regulates NF-kappaB activity in hematopietic progenitor cells. J. Immunol. 167 (2001) 4458-4467
14. Chitnis A.B. The role of Notch in lateral inhibition and cell fate specification. Mol. Cell. Neurosci. 6 (1995) 311-321
15. Cui X.Y., Hu Q.D., Tekaya M., Shimoda Y., Ang B.T., Nie D.Y., Sun L., Hu W.P., Karsak M., Duka T., Takeda Y., Ou L.Y., Dawe G.S., Yu F.G., Ahmed S., Jin L.H., Schachner M., Watanabe K., Arsenijevic Y., and Xiao Z.C. NB-3/Notch 1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J. Biol. Chem. 279 (2004) 25858-25865
16. Dovey, H.F., John, V., Anderson, J.P., Chen, L.Z., de Saint Andrieu, P., Fang, L.Y., Freedman, S.B., Folmer, B., Goldbach, E., Holsztynska, E.J., Hu, K.L., Johnson-Wood, K.L., Kennedy, S.L., Kholodenko, D., Knops, J.E., Latimer, L.H., Lee, M., Liao, Z., Lieberburg, I.M., Motter, R.N., Mutter, L.C. et al., 2001. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. 76, 173-81.
17. Elyaman W., Bradshaw E.M., Wang Y., Oukka M., Kivisakk P., Chiba S., Yaqita H., and Khoury S.J. JAGGED1 and delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis. J. Immunol. 179 (2007) 5990-5998
18. Fang T.C., Yashiro-Ohtani Y., Del Bianco C., Knoblock D.M., Blacklow S.C., and Pear W.S. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity 27 (2007) 100-110
19. Fleisher A.S., Raman R., Siemers E.R., Becerra L., Clark C.M., Dean R.A., Farlow M.R., Galvin J.E., Peskind E.R., Quinn J.F., Sherzai A., Sowell B.B., Aisen P.S., and Thal L.J. Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease. Arch. Neurol. 65 (2008) 1031-1038
20. Folzt D.R., Santiago M.C., Berechid B.E., and Nye J.S. Glycogen synthase kinase-3beta modulates notch signaling and stability. Curr. Biol. 12 (2002) 1006-1011
21. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 6 (2005) 1142-1151
22. Genoud S., Lappe-Siefke C., Goebbels S., Radtke F., Aguet M., Scherer S.S., Suter U., Nave K.A., and Mantei N. Notch1 control of oligodendrocyte differentiation in the spinal cord. J. Cell. Biol. 158 (2002) 709-718
23. Grandbarbe L., Michelucci A., Heurtaux T., Hemmer K., Morga E., and Heuschling P. Notch signaling modulates the activation of microglial cells. Glia 55 (2007) 1519-1530
24. Hoyne G.F., Le Roux I., Corsin-Jimenez M., Tan K., Dunne J., Forsyth L.M., Dallman M.J., Owen M.J., Ish-Horowicz D., and Lamb J.R. Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. Int. Immunol. 12 (2000) 177-185
25. Hu Q.D., Ang B.T., Karsak M., Hu W.P., Cui X.Y., Duka T., Takeda Y., Chia W., Sankar N., Ng Y.K., Ling E.A., Maciag T., Small D., Trifonova R., Kopan R., Okano H., Nakafuku M., Chiba S., Hirai H., Aster J.C., Schachner M., Pallen C.J., Watanabe K., and Xiao Z.C. F3/Contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 115 (2003) 163-175
26. Hu X., Chung A.Y., Wu I., Foldi J., Chen J., Ji J.D., Tateya T., Kang Y.J., Han J., Gessler M., Kageyama R., and Ivashkiv L.B. Integrated regulation of Toll-like receptor responses by Notch and interferon-gamma pathways. Immunity 29 (2008) 691-703
27. Jehn B.M., Bielke W., Pear W.S., and Osborne B.A. Cutting edge: protective effects of notch-1 on TCR-induced apoptosis. J. Immunol. 162 (1999) 635-638
28. John G.R., Shankar S.L., Shafit-Zagardo B., Massimi A., Lee S.C., Raine C.S., and Brosnan C.F. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat. Med. 8 (2002) 1115-1121
29. Jurynczyk M., Jurewicz A., Bielecki B., Raine C.S., and Selmaj K. Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J. Neuroimmunol. 170 (2005) 3-10
30. Jurynczyk M., Jurewicz A., Raine C.S., and Selmaj K. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and attenuates experimental autoimmune encephalomyelitis. J. Immunol. 180 (2008) 2634-2640
31. Krishnamoorthy N., Oriss T.B., Paglia M., Fei M., Yarlagadda M., Vanhaesebroeck B., Ray A., and Ray P. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat. Med. 14 (2008) 565-573
32. Le Borgne R. Regulation of Notch signaling by endocytosis and endosomal sorting. Curr. Opin. Cell Biol. 18 (2006) 213-222
33. Lee J.E. Basic helix-loop-helix genes in neural development. Curr. Opin. Neurobiol. 7 (1997) 13-20
34. Maekawa Y., Tsukomo S., Chiba S., Hirai H., Hayashi Y., Okada H., Kishihara K., and Yasutomo K. Delta1-Notch3 interactions bias the functional differentiation of activated CD4+ T cells. Immunity 19 (2003) 549-559
35. Mastronardi F.G., Min W., Wang H., Winer S., Dosch M., Boggs J.M., and Moscarello M.A. Attenuation of experimental autoimmune encephalomyelitis and nonimmune demyelination by IFN-beta plus vitamin B12: treatment to modify notch-1/sonic hedgehog balance. J. Immunol. 172 (2004) 6418-6426
36. McKenzie G., Ward G., Stallwood Y., Briend E., Papadia S., Lennard A., Turner M., Champion B., and Hardingham G.E. Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals. BMC Cell Biol. 7 (2006) 10
37. Minter L.M., Turley D.M., Das P., Shin H.M., Joshi I., Lawlor R.G., Cho O.H., Palaga T., Gottipati S., Telfer J.C., Kostura L., Fauq A.H., Simpson K., Such K.A., Miele L., Golde T.E., Miller S.D., and Osborne B.A. Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21. Nat. Immunol. 6 (2005) 680-688
38. Nakahara J., Kanekura K., Nawa M., Aiso S., and Suzuki N. Abnormal expression of TIP30 and arrested nucleocytoplasmic transport within oligodendrocyte precursor cells in multiple sclerosis. J. Clin. Invest. 119 (2009) 169-181
39. Napolitani G., Rinaldi A., Bertoni F., Sallusto F., and Lanzavecchia A. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6 (2005) 769-776
40. Ong C.T., Cheng H.T., Chang L.W., Ohtsuka T., Kageyama R., Stormo G.D., and Kopan R. Target selectivity of vertebrate notch proteins. Collaboration between discrete domains and CSL-binding site architecture determines activation probability. J. Biol. Chem. 281 (2006) 5106-5119
41. Ong C.T., Sedy J.R., Murphy K.M., and Kopan R. Notch and presenilin regulate cellular expansion and cytokine secretion but cannot instruct Th1/Th2 fate acquisition. PLoS ONE 3 (2008) e2823
42. Oswald F., Liptay S., Adler G., and Schmid R.M. NF-kappaB2 is a putative target gene of a activated Notch-1 via RBP-Jkappa. Mol. Cell. Biol. 18 (1998) 2077-2088
43. Palaga T., Miele L., Golde T.E., and Osborne B.A. TCR-mediated Notch signaling regulates proliferation and IFN-gamma production in peripheral T cells. J. Immunol. 171 (2003) 3019-3024
44. Palaga T., Buranaruk C., Rengpipat S., Fauq A.H., Golde T.E., Kaufmann S.H., and Osborne B.A. Notch signaling is activated by TLR stimulation and regulates macrophage functions. Eur. J. Immunol. 38 (2008) 174-183
45. Park H.C., and Appel B. Delta-Notch signaling regulates oligodendrocyte specification. Development 130 (2003) 3747-3755
46. Sade H., Krishna S., and Sarin A. The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt-PKB-mediated signaling in T cells. J. Biol. Chem. 279 (2004) 2937-2944
47. Sanders P., and De Keyser J. Janus faces of microglia in multiple sclerosis. Brain Res. Rev. 54 (2007) 274-285
48. Seifert T., Bauer J., Weissert R., Fazekas F., and Storch M.K. Notch1 and its ligand Jagged1 are present in remyelination in a T-cell- and antibody-mediated model of inflammatory demyelination. Acta Neuropathol. 113 (2007) 195-203
49. Shimizu K., Chiba S., Saito T., Kumano K., and Hirai H. Physical interaction of Delta1, Jagged1, and Jagged2 with Notch1 and Notch3 receptors. Biochem. Biophys. Res. Commun. 276 (2000) 385-389
50. Shimizu K., Chiba S., Saito T., Kumano K., Hamada Y., and Hirai H. Functional diversity among Notch1, Notch2, and Notch3 receptors. Biochem. Biophys. Res. Commun. 291 (2002) 775-779
51. Siemers E., Skinner M., Dean R.A., Gonzales C., Satterwhite J., Farlow M., Ness D., and May P.C. Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers. Clin. Neuropharmacol. 28 (2005) 126-132
52. Skokos D., and Nussenzweig M.C. CD8-DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J. Exp. Med. 204 (2007) 1525-1531
53. Stidworthy M.F., Genoud S., Li W.W., Leone D.P., Mantei N., Suter U., and Franklin R.J. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 127 (2004) 1928-1941
54. Talora C., Campese A.F., Bellavia D., Felli M.P., Vacca A., Gulino A., and Screpanti I. Notch signaling and diseases: an evolutionary journey from a simple beginning to complex outcomes. Biochim. Biophys. Acta 1782 (2008) 489-497
55. Teachey D.T., Seif A.E., Brown V.I., Bruno M., Bunte R.M., Chang Y.J., Choi J.K., Fish J.D., Hall J., Reid G.S., Ryan T., Sheen C., Zweidler-McKay P., and Grupp S.A. Targeting Notch signaling in autoimmune and lymphoproliferative disease. Blood 111 (2008) 705-714
56. Tu L., Fang T.C., Artis D., Shestova O., Pross S.E., Maillard I., and Pear W.S. Notch signaling is an important regulator of type 2 immunity. J. Exp. Med. 202 (2005) 1037-1042
57. Vacca A., Felli M.P., Palermo R., Di Mario G., Calce A., Di Giovine M., Frati L., Gulino A., and Screpanti I. Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia. EMBO J. 25 (2006) 1000-1008
58. Vigouroux S., Yvon E., Wagner H.J., Biagi E., Dotti G., Sili U., Lira C., Rooney C.M., and Brenner M.K. Induction of antigen-specific regulatory T cells following overexpression of a Notch ligand by human B lymphocytes. J. Virol. 77 (2003) 10872-10880
59. Wang S., Sdrulla A.D., diSibio G., Bush G., Nofziger D., Hicks C., Weinmaster G., and Barres B.A. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21 (1998) 63-75
60. Weijzen S., Velders M.P., Elmishad A.G., Bacon P.E., Panella J.R., Nickoloff B.J., Miele L., and Kast W.M. The Notch ligand Jagged-1 is able to induce maturation of monocyte-derived human dendritic cells. J. Immunol. 169 (2002) 4273-4278
61. Wolfe M.S. Inhibition and modulation of gamma-secretase for Alzheimer's disease. Neurotherapeutics 5 (2008) 391-398
62. Yang L.T., Nichols J.T., Yao C., Manilay J.O., Robey E.A., and Weinmaster G. Fringe glycosyltransferases differentially modulate Notch proteolysis induced by Delta1 and Jagged1. Mol. Biol. Cell. 16 (2005) 927-942
63. Yvon E.S., Vigouroux S., Rousseau R.F., Biagi E., Amrolia P., Dotti G., Wagner H.J., and Brenner M.K. Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. Blood 102 (2003) 3815-3821